• Press Release

RMA of New York and Mount Sinai Health System Launch Oncofertility Program

Empowers cancer patients by increasing awareness of and access to fertility preservation options

  • New York, NY
  • (August 14, 2018)

Reproductive Medicine Associates of New York (RMA of New York), a Manhattan-based fertility center, and the Mount Sinai Health System have launched an innovative, integrated oncofertility program at The Blavatnik Family – Chelsea Medical Center at Mount Sinai to provide individuals and couples the benefit of advanced medical technologies to help with someday building their families.

Oncofertility is the field of medicine focused on reducing the negative effects of cancer treatments on an individual’s reproductive system. Oncofertility treatments include egg and embryo freezing, as well as sperm cryopreservation. The eggs, embryos, and sperm can be stored indefinitely until a patient or couple is ready to have children. The program has a committed and compassionate team of reproductive specialists who work closely with the oncology team to ensure integrated, seamless coordination and supervision of patient care.

“RMA of New York and Mount Sinai are committed to increasing awareness of oncofertility options,” says Alan Copperman, MD, Director of Reproductive Endocrinology and Infertility at the Icahn School of Medicine at Mount Sinai. “We provide a multi-disciplinary approach designed to empower patients during a very challenging time to realize the desire to have children. Arming patients with the knowledge of options available to them after cancer treatment is our goal.”

Jovana Lekovich, MD, an RMA of New York physician and Director of the Oncofertility Program, will work in close collaboration with Mount Sinai oncologists to coordinate care and fertility preservation options for those entering into cancer treatment. “An important yet often overlooked aspect of cancer treatment is the frequent negative impact on human fertility. With the advancement of science, medicine, and technology, cancer survival rates have increased tremendously in the past two decades. By focusing on fertility preservation prior to cancer treatment, we focus on survival and quality of life after cancer,” says Dr. Lekovich.  

Dr. Lekovich is a board certified obstetrician and gynecologist and reproductive endocrinologist and infertility specialist.  She specializes in all aspects of reproductive medicine and infertility, including conditions such as amenorrhea, polycystic ovary syndrome, and diminished ovarian reserve with ovulation induction, intrauterine insemination, in vitro fertilization, intracytoplasmic sperm injection, and preimplantation genetic testing of embryos.

“The Oncofertility Program together with the full range of oncology services offered at The Blavatnik Family – Chelsea Medical Center at Mount Sinai provides the most advanced fertility preservation techniques with the comfort and compassion that every cancer patient needs,” said Luis Isola, MD, Medical Director of Mount Sinai Cancer.

Dr. Lekovich is available for consultation at The Blavatnik Family – Chelsea Medical Center at Mount Sinai, 325 West 15th Street in Manhattan, on Mondays and Thursdays. To schedule an appointment, call 212-604-6059.

About Reproductive Medicine Associates of New York

Reproductive Medicine Associates of New York (RMA of New York) is widely recognized as a global leader in state-of-the-art reproductive medicine. Led by an integrated team of doctors and scientists with extensive reproductive endocrinology, fertility and urology experience and training, RMA of New York consistently reports IVF success rates to the Society for Assisted Reproductive Technology (SART) and the Center for Disease Control and Prevention (CDC) and is internationally recognized for achieving high success rates in the treatment of infertility. RMA of New York maximizes access to care by helping patients explore all insurance coverage and financing options available for treatment. RMA of New York is sensitive to the needs of the LGBTQ+ community, women choosing single parent motherhood, and women pursuing fertility preservation for elective indications as well as those in need of oncofertility services. Headquartered in midtown Manhattan, RMA of New York has six patient care facilities throughout New York, including three facilities in Manhattan, as well as in Brooklyn, Long Island, Westchester, and abroad in Mexico City. For more information, please visit www.rmany.com.


About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across eight hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2023-2024.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.